Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M. Kuderer, Kerry L. Reynolds, Petros Grivas et al.|The Lancet|2020Cited by 1.8k
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer ConsortiumPetros Grivas, Shuchi Gulati, Ali Raza Khaki et al.|Annals of Oncology|2021Cited by 326
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19Michael A. Thompson, KM Steve Lo, Jeffrey P. Henderson et al.|JAMA Oncology|2021Cited by 185
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R. Rivera, Jeremy L. Warner, Solange Peters et al.|Cancer Discovery|2020Cited by 138
Breath-Based Diagnosis of Invasive Mucormycosis (IM)Seena Koshy, Sophia Koo, Nour Ismail et al.|Open Forum Infectious Diseases|2017Cited by 25